Literature DB >> 7911655

Characterisation of antisera raised against species-specific peptide sequences from scrapie-associated fibril protein and their application for post-mortem immunodiagnosis of spongiform encephalopathies.

U Oberdieck1, Y G Xi, M Pocchiari, H Diringer.   

Abstract

Transmissible spongiform encephalopathies (TSE), such as scrapie or Creutzfeldt-Jakob disease (CJD), are fatal neurodegenerative diseases of the central nervous system caused by a yet unidentified virus. They are accompanied by a brain specific amyloidosis, during which a host coded protein irreversibly aggregates to form the scrapie-associated fibrils. The diagnosis of TSE relies on histopathological detection of spongiform lesions, on electron microscopical detection of fibrils, or on the immunological detection of SAF protein, which is the most specific diagnostic marker. In order to improve the diagnosis of TSE, we developed a protocol for rapid tissue fractionation and enrichment of SAF protein which subsequently allows the specific detection of SAF protein by western blotting and immunodetection. Using some new antisera raised against synthetic peptides with sequences specific for the hamster, sheep, cattle and human SAF protein, several samples can be diagnosed for TSE within 24 hours, starting with only 10-100 mg of brain tissue from different species.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7911655     DOI: 10.1007/bf01538820

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  43 in total

1.  Regional mapping of prion proteins in brain.

Authors:  A Taraboulos; K Jendroska; D Serban; S L Yang; S J DeArmond; S B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

Review 2.  Chemistry and biology of prions.

Authors:  S B Prusiner
Journal:  Biochemistry       Date:  1992-12-15       Impact factor: 3.162

Review 3.  The scrapie fibril protein and its cellular isoform.

Authors:  J Hope; J Manson
Journal:  Curr Top Microbiol Immunol       Date:  1991       Impact factor: 4.291

4.  Organ distribution of proteinase-resistant prion protein in humans and mice with Creutzfeldt-Jakob disease.

Authors:  T Kitamoto; S Mohri; J Tateishi
Journal:  J Gen Virol       Date:  1989-12       Impact factor: 3.891

5.  Isolation and structural studies of the intact scrapie agent protein.

Authors:  D C Bolton; P E Bendheim; A D Marmorstein; A Potempska
Journal:  Arch Biochem Biophys       Date:  1987-11-01       Impact factor: 4.013

6.  Abnormal fibrils from scrapie-infected brain.

Authors:  P A Merz; R A Somerville; H M Wisniewski; K Iqbal
Journal:  Acta Neuropathol       Date:  1981       Impact factor: 17.088

7.  Towards purification of the scrapie agent.

Authors:  H Diringer; H Hilmert; D Simon; E Werner; B Ehlers
Journal:  Eur J Biochem       Date:  1983-08-15

8.  Characterization of antisera against scrapie-associated fibrils (SAF) from affected hamster and cross-reactivity with SAF from scrapie-affected mice and from patients with Creutzfeldt-Jakob disease.

Authors:  L Bode; M Pocchiari; H Gelderblom; H Diringer
Journal:  J Gen Virol       Date:  1985-11       Impact factor: 3.891

9.  Abnormal isoform of prion proteins accumulates in the synaptic structures of the central nervous system in patients with Creutzfeldt-Jakob disease.

Authors:  T Kitamoto; R W Shin; K Doh-ura; N Tomokane; M Miyazono; T Muramoto; J Tateishi
Journal:  Am J Pathol       Date:  1992-06       Impact factor: 4.307

10.  Scrapie-associated precursor proteins: antigenic relationship between species and immunocytochemical localization in normal, scrapie, and Creutzfeldt-Jakob disease brains.

Authors:  J Safar; M Ceroni; P Piccardo; D C Gajdusek; C J Gibbs
Journal:  Neurology       Date:  1990-03       Impact factor: 9.910

View more
  2 in total

1.  Identification of a prion protein epitope modulating transmission of bovine spongiform encephalopathy prions to transgenic mice.

Authors:  M R Scott; J Safar; G Telling; O Nguyen; D Groth; M Torchia; R Koehler; P Tremblay; D Walther; F E Cohen; S J DeArmond; S B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

2.  Creutzfeldt-Jakob disease in Austria.

Authors:  J A Hainfellner; K Jellinger; H Diringer; M Guentchev; R Kleinert; P Pilz; H Maier; H Budka
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-08       Impact factor: 10.154

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.